Linked Data API

Show Search Form

Search Results

1129326
registered interest false more like this
date less than 2019-06-03more like thismore than 2019-06-03
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to recent trends in the number of community pharmacies closing, what his policy is on community pharmacy. more like this
tabling member constituency North Durham more like this
tabling member printed
Mr Kevan Jones more like this
uin 259073 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-07more like thismore than 2019-06-07
answer text <p>The Department is closely monitoring the market to identify and address issues that may impact patient access to pharmacy services. Access to National Health Service pharmaceutical services remains good: there are over 11,500 pharmacies in England, an increase of approximately 12% in the last decade.</p><p>In December 2016, as part of a wider package of reforms and to maintain access to NHS pharmaceutical services, the Government introduced the Pharmacy Access Scheme, which helps to support the financial viability of pharmacies in areas with fewer pharmacies.</p><p> </p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-06-07T14:44:47.577Zmore like thismore than 2019-06-07T14:44:47.577Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
1438
label Biography information for Mr Kevan Jones more like this
1123573
registered interest false more like this
date less than 2019-04-29more like thismore than 2019-04-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans his Department has to use community pharmacies to reduce pressure on urgent care services across England as part of the NHS Long Term Plan. more like this
tabling member constituency Houghton and Sunderland South more like this
tabling member printed
Bridget Phillipson more like this
uin 248663 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-02more like thismore than 2019-05-02
answer text <p>Both the NHS Long Term Plan and the Prevention is Better than Cure vision document set out an ambition to better utilise the skills and expertise within community pharmacy. The NHS Long Term Plan introduces the development of pharmacy connection schemes that will enable patients, who do not need primary medical services, to be referred from NHS 111 and General Practitioner practices, to a community pharmacy for support and advice with a minor illness.</p><p> </p><p>The Department, with NHS England, has recently begun negotiations to determine the Community Pharmacy Contractual Framework for 2019/20 and beyond. These negotiations will include discussions about the role of community pharmacy as set out within the NHS Long Term Plan. As the negotiations are confidential, no further detail can be provided at this time.</p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-05-02T15:53:47.237Zmore like thismore than 2019-05-02T15:53:47.237Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4046
label Biography information for Bridget Phillipson more like this
1123120
registered interest false more like this
date less than 2019-04-25more like thismore than 2019-04-25
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to expand existing public health and prevention services in community pharmacies in order to support the aims of the NHS Long Term Plan. more like this
tabling member constituency Houghton and Sunderland South more like this
tabling member printed
Bridget Phillipson more like this
uin 247688 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-04-30more like thismore than 2019-04-30
answer text <p>Both the NHS Long Term Plan and the ‘Prevention is Better than Cure’ vision document, published in November 2018, set out an ambition to encourage more people to make the most of their local pharmacy to stay well in the community. Within the prevention vision, the value of the advice and wide range of lifestyle and public health interventions being delivered by more than 9,500 community pharmacies already accredited as healthy living pharmacies was recognised. In line with this, the NHS Long Term Plan outlines an aim for voluntary sector partners, community pharmacists and general practitioner practices to work together to facilitate opportunities for the public to check on their health, through tests for high blood pressure and other high-risk conditions.</p><p>The Department is now developing a Green Paper to further work up this ambition and plans for delivering it. This will be published later this year.</p><p>Alongside this, the Department, with NHS England, has now begun negotiations to determine the Community Pharmacy Contractual Framework for 2019/20 and beyond. These are confidential negotiations and as such we are unable to provide further detail at this time.</p>
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-04-30T14:35:25.477Zmore like thismore than 2019-04-30T14:35:25.477Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4046
label Biography information for Bridget Phillipson more like this
1092658
registered interest false more like this
date less than 2019-03-21more like thismore than 2019-03-21
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect on aseptic compounding pharmacies operated by (a) NHS organisations and (b) non-NHS organisations of the UK leaving the EU without a deal. more like this
tabling member constituency Cambridge more like this
tabling member printed
Daniel Zeichner more like this
uin 235307 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-03-28more like thismore than 2019-03-28
answer text <p>Hospital pharmacy aseptic services can be provided under either:</p><p>- a specific exemption for pharmacists within medicine legislation (derived from section 10 of the Medicines Act 1968); or</p><p>- a specials manufacturing licence from the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Either approach requires services to meet the standards set by the MHRA within nationally recognised Good Manufacturing Practice. Licensed facilities are inspected by the MHRA and section 10 facilities are audited by regional quality assurance specialists under an Executive Letter, describing the arrangements for auditing unlicensed National Health Service aseptic units. The outcomes and risk ratings are reviewed through the NHS England Specialist Pharmacy Service.</p><p> </p><p>Commercial aseptic pharmacies must hold a specials manufacturing licence from the MHRA to supply compounded aseptic products to the NHS. The MHRA has its own inspection team who visit and review licensed facilities including both NHS and commercial. The MHRA has regulatory enforcement powers to close, restrict or require improvement in these licensed facilities.</p><p> </p><p>Capital spend to support individual pharmacy, aseptic or other NHS compounding services has historically been locally determined or has been part of wider whole hospital developments and, as such, there is no central repository of such spend.</p><p> </p><p>NHS Improvement has, through the initial work of reviewing NHS-provided aseptic services, identified a range of challenges linked to such services, including workforce. The next stage of this work will focus on workforce provision within the wider strategic review. This work does not include non-NHS organisations. Health Education England is undertaking a review that, linked with the NHS Improvement strategic service review, will identify the pharmacy technical services workforce issues across all grades and workforce groups.</p><p> </p><p>Aseptically compounded products are prepared from medicines that, in line with all medicines, are covered by the Department’s European Union exit planning process and products would all be included within the six-week additional stockpiling being managed through pharmaceutical suppliers.</p><p><strong> </strong></p><p><strong> </strong></p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
grouped question UIN
235304 more like this
235305 more like this
235306 more like this
question first answered
less than 2019-03-28T16:18:41.68Zmore like thismore than 2019-03-28T16:18:41.68Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
4382
label Biography information for Daniel Zeichner more like this
1055310
registered interest false more like this
date less than 2019-02-05more like thismore than 2019-02-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the quantity of drugs having to be disposed of by NHS pharmacies; and what reasons are given for the disposal of those drugs. more like this
tabling member constituency Birkenhead more like this
tabling member printed
Frank Field more like this
uin 216984 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-02-08more like thismore than 2019-02-08
answer text <p>The Department has made no recent estimate of the quantity of drugs having to be disposed by National Health Service pharmacies.</p><p> </p><p>However, research commissioned by the Department to determine the scale, causes and costs of waste medicines in England and published in November 2010, found that the gross cost of unused prescription medicines in primary and community care in the NHS in England in 2009 was £300 million a year and that up to £150 million of this amount was avoidable.</p><p> </p><p>Much of the waste identified was not caused by failures on the part of either patients or professionals, but by factors such as illnesses progressing and treatment changes being required.</p><p> </p><p>It also found that the NHS was managing the problem of medicines wastage more robustly than ever before, wastage of medicines was not a systemic problem in the NHS and was no worse than other comparable countries.</p><p> </p><p>The report is available at the following link:</p><p> </p><p><a href="http://discovery.ucl.ac.uk/1350234/1/Evaluation_of_NHS_Medicines_Waste__web_publication_version.pdf" target="_blank">http://discovery.ucl.ac.uk/1350234/1/Evaluation_of_NHS_Medicines_Waste__web_publication_version.pdf</a></p><p> </p><p>Nevertheless, NHS England is taking further action to promote medicines optimisation, such that patients receive the right medicine, at the right dosage, at the right time, and mitigate medicines wastage. This includes the deployment of clinical pharmacists in general practice and care homes to undertake structured medication reviews.</p><p> </p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-02-08T14:53:30.807Zmore like thismore than 2019-02-08T14:53:30.807Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
478
label Biography information for Lord Field of Birkenhead more like this
1055311
registered interest false more like this
date less than 2019-02-05more like thismore than 2019-02-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will take steps to enable NHS pharmacies to redistribute sealed quantities of drugs that would otherwise become surplus and remain unused, for approved medical purposes (a) in the UK or (b) as part of the UK's international development programme. more like this
tabling member constituency Birkenhead more like this
tabling member printed
Frank Field more like this
uin 216985 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-02-08more like thismore than 2019-02-08
answer text <p>The Department is concerned about wastage from unused medicines and is keen to minimise unnecessary extra costs. However, it does not promote the reuse of returned medicines that have left a pharmacy and returned unused by patients. This is because it is not possible to guarantee the quality of returned medicines on physical inspection alone. When medicines are returned from patients’ homes, there is no way of knowing whether the medicines have been stored or handled appropriately. Some medicines may deteriorate if, for example, left too close to a radiator, in direct sunlight or exposed to the environment.</p><p> </p><p>As far as the United Kingdom’s international development programme is concerned, the World Health Organization’s ‘Guidelines for Medicines Donations’ updated in 2010 should be followed, which state that there should be no double standards in quality. If the quality of an item is unacceptable in the donor country, it is also unacceptable as a donation. The guidelines are available at the following link:</p><p> </p><p><a href="https://apps.who.int/iris/bitstream/handle/10665/44647/9789241501989_eng.pdf;jsessionid=713DED104D92853AAAE51F04C521CAF7?sequence=1" target="_blank">https://apps.who.int/iris/bitstream/handle/10665/44647/9789241501989_eng.pdf;jsessionid=713DED104D92853AAAE51F04C521CAF7?sequence=1</a></p><p> </p><p>Although it wishes to help, the Department would wish to avoid being accused of dumping unwanted or substandard items on poor and developing countries, which it does not use for patients in this country.</p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-02-08T14:54:28.173Zmore like thismore than 2019-02-08T14:54:28.173Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
478
label Biography information for Lord Field of Birkenhead more like this
1054684
registered interest false more like this
date less than 2019-02-04more like thismore than 2019-02-04
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of enabling pharmacists to issue low-strength prescription drugs to reduce the workload for GPs. more like this
tabling member constituency Upper Bann more like this
tabling member printed
David Simpson more like this
uin 216187 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-02-12more like thismore than 2019-02-12
answer text <p>The Department has made no assessment of the merits of enabling pharmacists to issue ‘low-strength’ prescription drugs to reduce the workload for general practitioners.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-02-12T15:50:40.057Zmore like thismore than 2019-02-12T15:50:40.057Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
1597
label Biography information for David Simpson more like this
1037183
registered interest false more like this
date less than 2019-01-07more like thismore than 2019-01-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department has plans to renegotiate the community pharmacy contractual framework; and if he will make a statement. more like this
tabling member constituency Darlington more like this
tabling member printed
Jenny Chapman more like this
uin 205887 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-10more like thismore than 2019-01-10
answer text <p>The Department will be seeking to renegotiate the Community Pharmacy Contractual Framework. Community pharmacies play a vital role within our health and care system and the Department remains committed to working closely with the Pharmaceutical Services Negotiating Committee to better utilise the reach and skill set of pharmacy teams.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-01-10T17:17:09.04Zmore like thismore than 2019-01-10T17:17:09.04Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3972
label Biography information for Baroness Chapman of Darlington more like this
1037185
registered interest false more like this
date less than 2019-01-07more like thismore than 2019-01-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what recent discussions his Department has had with the Cabinet Office on potential reforms to the community pharmacy sector. more like this
tabling member constituency Darlington more like this
tabling member printed
Jenny Chapman more like this
uin 205888 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-10more like thismore than 2019-01-10
answer text <p>As is customary, the Department regularly engages the Cabinet Office across a wide range of policy issues. Ongoing discussions continue between the Department and the Cabinet Office on the role of community pharmacy and the important contribution of pharmacy teams as outlined in the NHS Long Term Plan.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-01-10T17:18:08.077Zmore like thismore than 2019-01-10T17:18:08.077Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3972
label Biography information for Baroness Chapman of Darlington more like this
1037190
registered interest false more like this
date less than 2019-01-07more like thismore than 2019-01-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Pharmacy remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to page 82 of the NHS Long Term Plan, what specific reforms to reimbursement and supply arrangements for community pharmacy his Department is considering. more like this
tabling member constituency Darlington more like this
tabling member printed
Jenny Chapman more like this
uin 205891 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-10more like thismore than 2019-01-10
answer text <p>As outlined in the published final package of, ‘Community Pharmacy in 2016/17 and beyond’<sup>1</sup>, the Government is committed to pursuing a number of reimbursement reforms and taking steps to improve the prescription ordering journey to maximise patient choice and convenience.</p><p> </p><p>The reimbursement reforms include:</p><p>- ‘non Part VIII’ products, i.e. products with no reimbursement price listed in Part VIII of the Drug Tariff;</p><p>- changes to Category M for certain generic medicines to better reflect their market price;</p><p>- changes to the margin survey to account for multiple suppliers for Non Part VIII products and Category C products;</p><p>- ‘splitting the discount’- to reflect that in general generic medicines have increased margin over brands; and</p><p>- changes to the way Category A prices are set.</p><p>The Government has also recently committed to reforming reimbursement arrangements for specials.</p><p> </p><p>Note:</p><p><sup>1</sup><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/561495/Community_pharmacy_package_A.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/561495/Community_pharmacy_package_A.pdf</a></p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-01-10T17:06:57.303Zmore like thismore than 2019-01-10T17:06:57.303Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3972
label Biography information for Baroness Chapman of Darlington more like this